Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis

Bone Marrow Transplantation

Volumn 19, Issue 10, 1997, Pages 963-968

  Ringden O ^a   Labopin, M ^b   Gluckman, E ^c   Hows, J M ^d   Bradley, B A ^d   Kolb, H J ^e   Fouillard, L ^b   Jacobsen, N ^f   Vernant, J P ^g   Witz, F ^h   Harousseau, J L ⁱ   Gorin, N C ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b HÔPITAL SAINT ANTOINE   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d SOUTHMEAD HOSPITAL   (United Kingdom)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f Rigshospitalet   (Denmark)

^g HENRI MONDOR HOSPITAL   (France)

^h Hôpital de Brobois   (France)

ⁱ NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Acute lymphoblastic leukaemia; Acute myeloid leukaemia; Autografting; Bone marrow transplant; Unrelated donors

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; AUTOGRAFT; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; DONOR; FEMALE; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0030993272     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700787     Document Type: Article

References (27)

1. McGlave PB, Beatty PG, Ash R, Hows JM. Therapy for chronic myelogenous leukaemia with unrelated donor bone marrow transplantation. Results in 102 cases. Blood 1990; 75: 1728-1732.
2. Howard MR, Hows JM, Gore SM et al. Unrelated donor marrow transplantation between 1977 and 1987 at four centres in the United Kingdom. Transplantation 1990; 49: 547-553.
3. Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991; 51: 443-447.
4. Hows J, Bradley BA, Gore S et al. Prospective evaluation of unrelated donor bone marrow transplantation. Bone Marrow Transplant 1993; 12: 371-380.
5. Marks DR, Cullis JO, Ward KN et al. Allogeneic bone marrow transplantation for chronic myeloid leukaemia, using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med 1993; 119: 207-214.
6. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New Engl J Med 1993; 328: 593-602.
7. Beatty PG, Anasetti C, Hansen JA et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood 1993; 81: 249-253.
8. Ringdén O, Remberger M, Persson U et al. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant 1995; 15: 619-625.
9. Mandelli F, Labopin M, Granena A et al. European survey of bone marrow transplantation in acute promyelocytic leukaemia (M3). Bone Marrow Transplant 1994; 14: 293-298.
10. Kaplan EI, Meier P. Non-parametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
11. Cox DR. Regression model and life tables. JR Stat Soc Ser B 1972; 34: 187-220.
12. Gale RP, Horowitz MM, Weiner RS et al. Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. Bone Marrow Transplant 1995; 16: 203-208.
13. Weiden PL, Flournoy N, Thomas ED et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. New Engl J Med 1979; 300: 1068-1073.
14. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukaemia reactions following bone marrow transplantation in humans. Blood 1989; 75: 555-562.
15. Saarinen U, Mellander L, Nysom K et al. Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukaemia: a retrospective case-control study in the Nordic Countries. Bone Marrow Transplant 1996; 17: 357-363.
16. Zhang M-J, Hoelzer D, Horowitz MM et al for the Acute Lymphoblastic Leukaemia Working Committee. Long-term follow-up of adults with acute lymphoblastic leukaemia in first remission treated with chemotherapy or bone marrow transplantation. Ann Intern Med 1995; 123: 428-431.
17. Proctor SJ, Hamilton PJ, Reid MM et al. A comparative study of combination chemotherapy vs marrow transplant in first remission in ALL. Bone Marrow Transplant 1987; 2 (Suppl. 1): 21.
18. Sebban C, Lepage E, Vernant JP et al. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukaemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukaemia. J Clin Oncol 1994; 12: 2580-2587.
19. Barrett AJ, Horowitz MM, Pollock BH et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission. New Engl J Med 1994; 331: 1253-1258.
20. Borgmann A, Schmid H, Hartmann E et al. Autologous bone marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. Lancet 1995; 346: 873-876.
21. Hermans J, Suciu S, Stijnen Th et al. Treatment of acute myelogenous leukaemia: an EBMT-EORTC retrospective analysis of chemotherapy vs allogeneic or autologous bone marrow transplantation. Eur J Oncol 1989; 25: 545-550.
22. Zittoun R, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukaemia. New Engl J Med 1995; 332: 217-223.
23. Gale RP, Horowitz MM, Rees JKH et al. Chemotherapy vs transplants for acute myelogenous leukemia in second remission. Leukemia 1996; 10: 13-19.
24. Busca A, Anasetti C, Anderson G et al. Unrelated donor or autologous marrow transplantation for treatment of acute leukemia. Blood 1994; 83: 3077-3084.
25. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tiss Ant 1992; 39: 225-235.
26. Petersdorf EW, Longton GM, Anasetti C et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, -B, -DR identical unrelated donor marrow transplantation. Blood 1995; 86: 1606-1613.
27. Gorin NC, Labopin M, Meloni G et al. Autologous bone marrow transplantation for acute myeloblastic leukaemia in Europe: further evidence of the role of marrow-purging by mafosfamide. Leukemia 1991; 5: 896-904.